These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18301920

  • 1. Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome.
    Crinò A, Di Giorgio G, Schiaffini R, Fierabracci A, Spera S, Maggioni A, Gattinara GC.
    Eur J Pediatr; 2008 Dec; 167(12):1455-8. PubMed ID: 18301920
    [Abstract] [Full Text] [Related]

  • 2. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.
    Ludwig NG, Radaeli RF, Silva MM, Romero CM, Carrilho AJ, Bessa D, Macedo DB, Oliveira ML, Latronico AC, Mazzuco TL.
    Arch Endocrinol Metab; 2016 Dec; 60(6):596-600. PubMed ID: 27982202
    [Abstract] [Full Text] [Related]

  • 3. Idiopathic central precocious puberty with Prader-Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog.
    Kobayashi M, Yagasaki H, Tamaru K, Mitsui Y, Inukai T.
    Endocrinol Diabetes Metab Case Rep; 2022 Aug 01; 2022():. PubMed ID: 36017812
    [Abstract] [Full Text] [Related]

  • 4. Treatment of precocious puberty in a female with Prader-Willi syndrome.
    Pusz ER, Rotenstein D.
    J Pediatr Endocrinol Metab; 2008 May 01; 21(5):495-500. PubMed ID: 18655533
    [Abstract] [Full Text] [Related]

  • 5. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
    Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A.
    Clin Endocrinol (Oxf); 2012 Jan 01; 76(1):72-7. PubMed ID: 21718342
    [Abstract] [Full Text] [Related]

  • 6. Central precocious puberty in a girl with Prader-Willi syndrome.
    Lee HS, Hwang JS.
    J Pediatr Endocrinol Metab; 2013 Jan 01; 26(11-12):1201-4. PubMed ID: 23740678
    [Abstract] [Full Text] [Related]

  • 7. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade.
    Hirsch HJ, Eldar-Geva T, Bennaroch F, Pollak Y, Gross-Tsur V.
    Hum Reprod; 2015 Nov 01; 30(11):2587-96. PubMed ID: 26345685
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart- Willi syndrome.
    Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M.
    J Clin Endocrinol Metab; 2006 Mar 01; 91(3):892-8. PubMed ID: 16352691
    [Abstract] [Full Text] [Related]

  • 9. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan 01; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 10. Puberty in girls with Prader-Willi syndrome: cohort evaluation and clinical recommendations in a Latin American tertiary center.
    Passone CGB, Aragão LFF, Franco RR, Leite JES, Gonzalez MAB, Schil PSA, Ybarra M, Damiani D, Kerkhof GF, Montenegro Junior RM, Silva CA.
    Front Endocrinol (Lausanne); 2024 Jan 01; 15():1403470. PubMed ID: 38966214
    [Abstract] [Full Text] [Related]

  • 11. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.
    J Pediatr Endocrinol Metab; 2000 Jul 01; 13 Suppl 1():811-20. PubMed ID: 10969926
    [Abstract] [Full Text] [Related]

  • 12. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP, Jones JV, Barnes KM, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 2000 Nov 01; 85(11):4036-8. PubMed ID: 11095429
    [Abstract] [Full Text] [Related]

  • 13. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.
    Hirsch HJ, Eldar-Geva T, Benarroch F, Rubinstein O, Gross-Tsur V.
    J Clin Endocrinol Metab; 2009 Jul 01; 94(7):2262-8. PubMed ID: 19401370
    [Abstract] [Full Text] [Related]

  • 14. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.
    Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, Gross-Tsur V.
    Eur J Endocrinol; 2010 Feb 01; 162(2):377-84. PubMed ID: 19946044
    [Abstract] [Full Text] [Related]

  • 15. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb 01; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 16. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F, Pescovitz OH, Rieth KG, Dwyer AJ, Hench K, McNemar A, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Nov 01; 59(5):888-92. PubMed ID: 6434587
    [Abstract] [Full Text] [Related]

  • 17. Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.
    Gaston LS, Stafford DE.
    J Pediatr Endocrinol Metab; 2023 Feb 23; 36(2):185-194. PubMed ID: 36458449
    [Abstract] [Full Text] [Related]

  • 18. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome.
    Eiholzer U, Grieser J, Schlumpf M, l'Allemand D.
    Horm Res; 2007 Feb 23; 68(4):178-84. PubMed ID: 17374959
    [Abstract] [Full Text] [Related]

  • 19. The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction.
    Gross-Tsur V, Hirsch HJ, Benarroch F, Eldar-Geva T.
    Reprod Biol Endocrinol; 2012 May 06; 10():39. PubMed ID: 22559970
    [Abstract] [Full Text] [Related]

  • 20. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug 06; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.